116 related articles for article (PubMed ID: 38361268)
21. Comprehensive analysis of the impact of emerging flame retardants on prostate cancer progression: The potential molecular mechanisms and immune infiltration landscape.
Xu X; Zhang D; Zhao K; Liu Z; Ren X; Zhang X; Lu Z; Qin C; Wang J; Wang S
Toxicology; 2024 Jan; 501():153681. PubMed ID: 38006928
[TBL] [Abstract][Full Text] [Related]
22. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
[TBL] [Abstract][Full Text] [Related]
23. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
24. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
[TBL] [Abstract][Full Text] [Related]
25. Identification and analysis of a CD8+ T cell-related prognostic signature for colorectal cancer based on bulk RNA sequencing and scRNA sequencing data: A STROBE-compliant retrospective study.
Pan Z; Li Q; Feng Y; Gao C; Pan F
Medicine (Baltimore); 2022 Sep; 101(39):e30758. PubMed ID: 36181098
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral immune heterogeneity of prostate cancer characterized by typing and hub genes.
Han J; Zhou Y; Zhang C; Feng J; Wang J; Guo K; Chen W; Li Y
J Cell Mol Med; 2023 Jan; 27(1):101-112. PubMed ID: 36524848
[TBL] [Abstract][Full Text] [Related]
27. Unraveling neoantigen-associated genes in bladder cancer: An in-depth analysis employing 101 machine learning algorithms.
Lv F; Xiong Q; Qi M; Dai C; Zhang X; Cheng S
Environ Toxicol; 2024 May; 39(5):2528-2544. PubMed ID: 38189174
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
29. Incidence of androgen receptor and androgen receptor variant 7 coexpression in prostate cancer.
Vellky JE; Bauman TM; Ricke EA; Huang W; Ricke WA
Prostate; 2019 Dec; 79(16):1811-1822. PubMed ID: 31503366
[TBL] [Abstract][Full Text] [Related]
30. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
[TBL] [Abstract][Full Text] [Related]
31. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
32. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.
Jia Y; Liu R; Shi L; Feng Y; Zhang L; Guo N; He A; Kong G
BMC Cancer; 2023 Sep; 23(1):859. PubMed ID: 37700273
[TBL] [Abstract][Full Text] [Related]
34. Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing.
Fu J; Li G; Luo R; Lu Z; Wang Y
Front Endocrinol (Lausanne); 2022; 13():1003594. PubMed ID: 36105400
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model.
Luo J; Lai C; Xu X; Shi J; Hu J; Guo K; Mulati Y; Xiao Y; Kong D; Liu C; Xu K
BMC Cancer; 2023 Aug; 23(1):741. PubMed ID: 37563543
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B
Front Immunol; 2022; 13():914577. PubMed ID: 35757739
[TBL] [Abstract][Full Text] [Related]
37. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma.
Zhang J; Li Y; Yang Y; Huang J; Sun Y; Zhang X; Kong X
Cancer Sci; 2024 Jan; 115(1):109-124. PubMed ID: 38015097
[TBL] [Abstract][Full Text] [Related]
38. A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG.
Shi H; Duan J; Chen Z; Huang M; Han W; Kong R; Guan X; Qi Z; Zheng S; Lu M
Clin Transl Oncol; 2023 Apr; 25(4):995-1010. PubMed ID: 36376702
[TBL] [Abstract][Full Text] [Related]
39. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
40. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
